Bioactive glass-based fibrous wound dressings

Shahin Homaeigohar , Meng Li , Aldo R. Boccaccini

Burns & Trauma ›› 2022, Vol. 10 ›› Issue (1) : tkac038

PDF (1179KB)
Burns & Trauma ›› 2022, Vol. 10 ›› Issue (1) :tkac038 DOI: 10.1093/burnst/tkac038
Review
research-article
Bioactive glass-based fibrous wound dressings
Author information +
History +
PDF (1179KB)

Abstract

Since the discovery of silicate bioactive glass (BG) by Larry Hench in 1969, different classes of BGs have been researched over decades mainly for bone regeneration. More recently, validating the beneficial influence of BGs with tailored compositions on angiogenesis, immunogenicity and bacterial infection, the applicability of BGs has been extended to soft tissue repair and wound healing. Particularly, fibrous wound dressings comprising BG particle reinforced polymer nanofibers and cotton-candy-like BG fibers have been proven to be successful for wound healing applications. Such fibrous dressing materials imitate the physical structure of skin's extracellular matrix and release biologically active ions e.g. regenerative, pro-angiogenic and antibacterial ions, e.g. borate, copper, zinc, etc., that can provoke cellular activities to regenerate the lost skin tissue and to induce new vessels formation, while keeping an anti-infection environment. In the current review, we discuss different BG fibrous materials meant for wound healing applications and cover the relevant literature in the past decade. The production methods for BG-containing fibers are explained and as fibrous wound dressing materials, their wound healing and bactericidal mechanisms, depending on the ions they release, are discussed. The present gaps in this research area are highlighted and new strategies to address them are suggested.

Keywords

Scaffolds / Fibers / Angiogenesis / Wound healing / Bioactive glass

Cite this article

Download citation ▾
Shahin Homaeigohar, Meng Li, Aldo R. Boccaccini. Bioactive glass-based fibrous wound dressings. Burns & Trauma, 2022, 10 (1) : tkac038 DOI:10.1093/burnst/tkac038

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Guest JF, Ayoub N, Mcilwraith T, Uchegbu I, Gerrish A, Weidlich D, et al. Health economic burden that wounds impose on the National Health Service in the UK. BMJ Open. 2015; 512: e009283.

[2]

Tronci G. The application of collagen in advanced wound dressings. In: Rajendran S (eds). Advanced Textiles for Wound Care. Duxford, United Kingdom: Woodhead Publishing-Elsevier, 2019, 363-89.

[3]

Naves CCLM. The diabetic foot: a historical overview and gaps in current treatment. Adv Wound Care. 2016; 55: 191-7.

[4]

http://www.marketsandmarkets.com/Market-Reports/wound-care-market-371.html.

[5]

Han G, Ceilley R. Chronic wound healing: a review of current management and treatments. Adv Ther. 2017;343: 599-610.

[6]

Martin P, Nunan R. Cellular and molecular mechanisms of repair in acute and chronic wound healing. Brit J Dermatol. 2015;1732: 370-8.

[7]

Haukipuro K, Melkko J, Risteli L, Kairaluoma MI, Risteli J. Synthesis of type-I collagen in healing wounds in humans. Ann Surg. 1991; 2131: 75-80.

[8]

Homaeigohar S, Monavari M, Koenen B, Boccaccini AR. Biomimetic biohybrid nanofibers containing bovine serum albumin as a bioactive moiety for wound dressing. Mater Sci Eng C-Mater. 2021; 123: 111965.

[9]

Homaeigohar S, Tsai TY, Zarie ES, Elbahri M, Young TH, Boccaccini AR. Bovine serum albumin (BSA)/polyacrylonitrile (PAN) biohybrid nanofibers coated with a biomineralized calcium deficient hydroxyapatite (HA) shell for wound dressing. Mater Sci Eng C-Mater. 2020; 116: 111248.

[10]

Zhou J, Wang H, Zhao SC, Zhou N, Li L, Huang WH, et al. In vivo and in vitro studies of borate based glass micro-fibers for dermal repairing. Mater Sci Eng C-Mater. 2016; 60: 437-45.

[11]

Rahaman MN, Day DE, Bal BS, Fu Q, Jung SB, Bonewald LF, et al. Bioactive glass in tissue engineering. Acta Biomater. 2011; 76: 2355-73.

[12]

Gatti AM, Valdre G, Andersson OH. Analysis of the in vivo reactions of a bioactive glass in soft and hard tissue. Biomaterials. 1994; 153: 208-12.

[13]

Gerhardt LC, Boccaccini AR. Bioactive glass and glass-ceramic scaffolds for bone tissue engineering. Materials. 2010; 37: 3867-910.

[14]

El-Rashidy AA, Roether JA, Harhaus L, Kneser U, Boccaccini AR. Regenerating bone with bioactive glass scaffolds: a review of in vivo studies in bone defect models. Acta Biomater. 2017; 62: 1-28.

[15]

Hench LL. The story of Bioglass. J Mater Sci Mater Med. 2006;1711: 967-78.

[16]

Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res. 2001; 552: 151-7.

[17]

Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;2715: 2907- 15.

[18]

Hoppe A, Guldal NS, Boccaccini AR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials. 2011;3211: 2757-74.

[19]

Mehrabi T, Mesgar AS, Mohammadi Z. Bioactive glasses: a promising therapeutic on release strategy for enhancing wound healing. ACS Biomater Sci Eng. 2020;610: 5399-430.

[20]

Hench LL, Splinter RJ, Allen W, Greenlee T. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res. 1971; 56: 117-41.

[21]

Hench LL. Bioceramics-from concept to clinic. J Am Ceram Soc. 1991; 747: 1487-510.

[22]

Qazi TH, Hafeez S, Schmidt J, Duda GN, Boccaccini AR, Lippens E. Comparison of the effects of 45S5 and 1393 bioactive glass microparticles on hMSC behavior. J Biomed Mater Res A. 2017;10510: 2772-82.

[23]

Fu Q, Rahaman MN, Bal BS, Brown RF, Day DE. Mechanical and in vitro performance of 13-93 bioactive glass scaffolds prepared by a polymer foam replication technique. Acta Biomater. 2008; 46: 1854-64.

[24]

Fu Q, Rahaman MN, Bal BS, Huang W, Day DE. Preparation and bioactive characteristics of a porous 13-93 glass, and fabrication into the articulating surface of a proximal tibia. J Biomed Mater Res A. 2007; 82a1: 222-9.

[25]

Deliormanli AM. Preparation, in vitro mineralization and osteoblast cell response of electrospun 13-93 bioactive glass nanofibers. Mater Sci Eng C. 2015; 53: 262-71.

[26]

Boccaccini AR, Brauer DS, Hupa L. Aldo R Boccaccini, Delia S Brauer, Leena Hupa (eds). Bioactive Glasses: Fundamentals, Technology and Applications. Cambridge, United Kingdom: Royal Society of Chemistry, 2016.

[27]

Huang WH, Day DE, Kittiratanapiboon K, Rahaman MN. Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions. J Mater Sci Mater Med. 2006; 177: 583-96.

[28]

Yao AH, Wang DP, Huang WH, Fu Q, Rahaman MN, Day DE. In vitro bioactive characteristics of borate-based glasses with controllable degradation behavior. J Am Ceram Soc. 2007; 901: 303-6.

[29]

Fu QA, Rahaman MN, Fu HL, Liu X. Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. J Biomed Mater Res A. 2010; 95a1: 164-71.

[30]

Marion CM, Liang W, Liang W, Reilly GC, Day DE, Rahaman M, Mao JJ. Borate glass supports the In vitro osteogenic differentiation of human mesenchymal stem cells. Mech Adv Mater Struct 2005; 12: 239-46.

[31]

Fu HL, Fu Q, Zhou N, Huang WH, Rahaman MN, Wang DP, et al. In vitro evaluation of borate-based bioactive glass scaffolds prepared by a polymer foam replication method. Mater Sci Eng C-Mater. 2009; 297: 2275-81.

[32]

Fu QA, Rahaman MN, Bal BS, Bonewald LF, Kuroki K, Brown RF. Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. J Biomed Mater Res A. 2010; 95a1: 172-9.

[33]

Liu X, Xie ZP, Zhang CQ, Pan HB, Rahaman MN, Zhang X, et al. Bioactive borate glass scaffolds: in vitro and in vivo evaluation for use as a drug delivery system in the treatment of bone infection. J Mater Sci Mater Med. 2010; 212: 575-82.

[34]

Jia WT, Zhang X, Luo SH, Liu X, Huang WH, Rahaman MN, et al. Novel borate glass/chitosan composite as a delivery vehicle for teicoplanin in the treatment of chronic osteomyelitis. Acta Biomater. 2010; 63: 812-9.

[35]

Zhang X, Jia WT, Gua YF, Wei XA, Liu X, Wang DP, et al. Teicoplanin-loaded borate bioactive glass implants for treating chronic bone infection in a rabbit tibia osteomyelitis model. Biomaterials. 2010;3122: 5865-74.

[36]

Lin YN, Brown RF, Jung SB, Day DE. Angiogenic effects of borate glass microfibers in a rodent model. J Biomed Mater Res A. 2014;10212: 4491-9.

[37]

Dalisson B, Barralet J. Bioinorganics and wound healing. Adv Healthc Mater. 2019;818 ARTN:1900764.

[38]

Brown RF, Rahaman MN, Dwilewicz AB, Huang W, Day DE, Li Y, et al. Effect of borate glass composition on its conversion to hydroxyapatite and on the proliferation of MC3T3-E1 cells. J Biomed Mater Res A. 2009; 88a2: 392-400.

[39]

Jung S, Day DE, Brown RF, Bonewald L. Potential toxicity of bioactive borate glasses in-vitro and in-vivo. Ceram Eng Sci Proc. 2013; 33: 65-74.

[40]

Huang WH, Rahaman MN, Day DE, Li YD. Mechanisms for converting bioactive silicate, borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solution. Phys Chem Glasses-B. 2006; 476: 647-58.

[41]

Zhao SC, Li L, Wang H, Zhang YD, Cheng XG, Zhou N, et al. Wound dressings composed of copper-doped borate bioactive glass microfibers stimulate angiogenesis and heal full-thickness skin defects in a rodent model. Biomaterials. 2015; 53: 379-91.

[42]

Ahmed I, Lewis M, Olsen I, Knowles JC. Phosphate glasses for tissue engineering: Part 1. Processing and characterisation of a ternary-based P(2)O(5)-CaO-Na(2)O glass system. Biomaterials. 2004; 253: 491-9.

[43]

Ahmed I, Lewis M, Olsen I, Knowles JC. Phosphate glasses for tissue engineering: Part 2. Processing and characterisation of a ternary-based P(2)O(5)-CaO-Na(2)O glass fibre system. Biomaterials. 2004; 253: 501-7.

[44]

Navarro M, Ginebra MP, Planell JA. Cellular response to calcium phosphate glasses with controlled solubility. J Biomed Mater Res A. 2003; 67a3: 1009-15.

[45]

Saranti A, Koutselas I, Karakassides MA. Bioactive glasses in the system CaO-B2O3-P2O5: preparation, structural study and in vitro evaluation. J Non-Cryst Solids. 2006; 3525: 390-8.

[46]

Ahmed I, Collins CA, Lewis MP, Olsen I, Knowles JC. Processing, characterisation and biocompatibility of iron-phosphate glass fibres for tissue engineering. Biomaterials. 2004; 2516: 3223-32.

[47]

Abou Neel EA, Ahmed I, Pratten J, Nazhat SN, Knowles JC. Characterisation of antibacterial copper releasing degradable phosphate glass fibres. Biomaterials. 2005; 2615: 2247-54.

[48]

Shu C, Wenjuan Z, Xu GH, Wei Z, Wei J, Dongmei W. Dissolution behavior and bioactivity study of glass ceramic scaffolds in the system of CaO-P2O5-Na2O-ZnO prepared by sol-gel technique. Mater Sci Eng C-Mater. 2010; 301: 105-11.

[49]

Lapa A, Cresswell M, Campbell I, Jackson P, Goldmann WH, Detsch R, et al. Ga and Ce ion-doped phosphate glass fibres with antibacterial properties and their composite for wound healing applications. J Mater Chem B. 2019; 745: 7246-6.

[50]

Gorustovich AA, Roether JA, Boccaccini AR. Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B-Rev. 2010;162: 199-207.

[51]

Durand LAH, Vargas GE, Vera-Mesones R, Baldi A, Zago MP, Fanovich MA, et al. In vitro human umbilical vein endothelial cells response to ionic dissolution products from lithium-containing 45S5 bioactive glass. Materials. 2017; 10: 740.

[52]

Mohammad G, Pandey H, Tripathib K. Diabetic wound healing and its angiogenesis with special reference to nanoparticles. Dig J Nanomater Bios. 2008; 3: 203-8.

[53]

Edwards JV, Howley PS. Human neutrophil elastase and collagenase sequestration with phosphorylated cotton wound dressings. J Biomed Mater Res A. 2007; 83a2: 446-54.

[54]

Nomi M, Atala A, De Coppi P, Soker S. Principals of neovascularization for tissue engineering. Mol Asp Med. 2002; 236: 463-83.

[55]

Madeddu P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol. 2005; 903: 315-26.

[56]

Tan Q, Chen B, Yan X, Lin Y, Xiao ZF, Hou XL, et al. Promotion of diabetic wound healing by collagen scaffold with collagen-binding vascular endothelial growth factor in a diabetic rat model. J Tissue Eng Regen Med. 2014; 83: 195-201.

[57]

Thawani JP, Wang AC, Than KD, Lin CY, La Marca F, Park P. Bone morphogenetic proteins and cancer: review of the literature. Neurosurgery. 2010; 662: 233-46.

[58]

Laurencin CT, Ashe KM, Henry N, Kan HM, Lo KWH. Delivery of small molecules for bone regenerative engineering: preclinical studies and potential clinical applications. Drug Discov Today. 2014; 196: 794-800.

[59]

Hanft J, Pollak R, Barbul A, Cv G, Kwon P, Gray S, et al. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. J Wound Care. 2008; 171: 30-7.

[60]

Uchi H, Igarashi A, Urabe K, Koga T, Nakayama J, Kawamori R, et al. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol. 2009; 195: 461-8.

[61]

Barralet J, Gbureck U, Habibovic P, Vorndran E, Gerard C, Doillon CJ. Angiogenesis in calcium phosphate scaffolds by inorganic copper ion release. Tissue Eng Part A. 2009; 157: 1601-9.

[62]

Gerard C, Bordeleau LJ, Barralet J, Doillon CJ. The stimulation of angiogenesis and collagen deposition by copper. Biomaterials. 2010; 315: 824-31.

[63]

Barbucci R, Lamponi S, Magnani A, Piras FM, Rossi A, Weber E. Role of the hyal-Cu (II) complex on bovine aortic and lymphatic endothelial cells behavior on microstructured surfaces. Biomacromolecules. 2005; 61: 212-9.

[64]

Hu GF. Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem. 1998; 693: 326-35.

[65]

Harris ED. A requirement for copper in angiogenesis. Nutr Rev. 2004; 622: 60-4.

[66]

Feng WK, Ye F, Xue WL, Zhou ZX, Kang YJ. Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol. 2009; 751: 174-82.

[67]

Borkow G, Gabbay J, Lyakhovitsky A, Huszar M. Improvement of facial skin characteristics using copper oxide containing pillowcases: a double-blind, placebo-controlled, parallel, randomized study. Int J Cosmetic Sci. 2009; 316: 437-43.

[68]

Gorter RW, Butorac M, Cobian EP. Examination of the cutaneous absorption of copper after the use of copper-containing ointments. Am J Ther. 2004; 116: 453-8.

[69]

Giavaresi G, Torricelli P, Fornasari PM, Giardino R, Barbucci R, Leone G. Blood vessel formation after soft-tissue implantation of hyaluronan-based hydrogel supplemented with copper ions. Biomaterials. 2005; 2616: 3001-8.

[70]

Chebassier N, El Houssein O, Viegas I, Dreno B. In vitro induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in keratinocytes by boron and manganese. Exp Dermatol. 2004; 138: 484-90.

[71]

Jung SB. Borate based bioactive glass scaffolds for hard and soft tissue engineering. Ph.D. thesis, Missouri University of Science and Technology, Missouri, United States, 2010. Available online at: https://scholarsmine.mst.edu/doctoral_dissertations/2075.

[72]

Wray P. ’Cotton candy’ that heals? Borate glass nanofibers look promising. Am Ceram Soc Bull. 2011; 904: 25-9.

[73]

Zhu YL, Ma ZJ, Kong LZ, He YH, Chan HF, Li HY. Modulation of macrophages by bioactive glass/sodium alginate hydrogel is crucial in skin regeneration enhancement. Biomaterials. 2020; 256: 120216.

[74]

Dong X, Chang J, Li HY. Bioglass promotes wound healing through modulating the paracrine effects between macrophages and repairing cells. J Mater Chem B. 2017; 526: 5240-50.

[75]

Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophth Vis Sci. 2003; 448: 3578-85.

[76]

Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, et al. Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature. 1989;3376206: 471-3.

[77]

Tsukamoto Y, Helsel WE, Wahl SM. Macrophage production of fibronectin, a chemoattractant for fibroblasts. J Immunol. 1981; 1272: 673-8.

[78]

Pakyari M, Farrokhi A, Maharlooei MK, Ghahary A. Critical role of transforming growth factor beta in different phases of wound healing. Adv Wound Care (New Rochelle). 2013; 25: 215-24.

[79]

Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 2004;3035659: 848-51.

[80]

Pieper JS, Hafmans T, van Wachem PB, van Luyn MJA, Brouwer LA, Veerkamp JH, et al. Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res. 2002; 622: 185-94.

[81]

Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005; 395: 733-42.

[82]

Tsuboi R, Rifkin DB. Recombinant basic fibroblast growth-factor stimulates wound-healing in healing-impaired Db/Db mice. J Exp Med. 1990; 1721: 245-51.

[83]

Jones JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater. 2013; 91: 4457-86.

[84]

Pirhonen E, Niiranen H, Niemela T, Brink M, Tormala P. Manufacturing, mechanical characterization, and in vitro performance of bioactive glass 13-93 fibers. J Biomed Mater Res B. 2006; 77b2: 227-33.

[85]

Stevens MM, George JH. Exploring and engineering the cell surface interface. Science. 2005;3105751: 1135-8.

[86]

Quintero F, Mann AB, Pou J, Lusquinos F, Riveiro A. Rapid production of ultralong amorphous ceramic nanofibers by laser spinning. Appl Phys Lett. 2007;9015: 153109.

[87]

Taygun ME, Boccaccini A. Nanoscaled bioactive glass particles and nanofibers. In: Heimo Ylänen (ed). Bioactive Glasses. Duxford, United Kingdom: Woodhead Publishing-Elsevier, 2018, 235-83.

[88]

Quintero F, Pou J, Comesana R, Lusquinos F, Riveiro A, Mann AB, et al. Laser spinning of bioactive glass nanofibers. Adv Funct Mater. 2009;1919: 3084-90.

[89]

Homaeigohar S, Boccaccini AR. Antibacterial biohybrid nanofibers for wound dressings. Acta Biomater. 2020; 107: 25-49.

[90]

Homaeigohar S, Strunskus T, Strobel J, Kienle L, Elbahri M. A flexible oxygenated carbographite nanofilamentous buckypaper as an amphiphilic membrane. Adv Mater Interfaces. 2018; 58: 1800001.

[91]

Abrigo M, McArthur SL, Kingshott P. Electrospun nanofibers as dressings for chronic wound care: advances, challenges, and future prospects. Macromol Biosci. 2014; 146: 772-92.

[92]

Rahmati M, Mills DK, Urbanska AM, Saeb MR, Venugopal JR, Ramakrishna S, et al. Electrospinning for tissue engineering applications. Prog Mater Sci. 2021; 117: 100721.

[93]

Bhardwaj N, Kundu SC. Electrospinning: a fascinating fiber fabrication technique. Biotechnol Adv. 2010;283: 325-47.

[94]

Zheng Y. 3-Fabrication on bioinspired surfaces. In: Bioinspired Design of Materials Surfaces. Elsevier, 2019, 99-146.

[95]

Felgueiras HP, Amorim MTP. Alina-Maria Holban, Alexandru Mihai Grumezescu (eds). Production of polymer-bioactive glass nanocomposites for bone repair and substitution. In: Materials for Biomedical Engineering. Amsterdam, Netherlands: Elsevier, 2019, 373-96.

[96]

Kouhi M, Morshed M, Varshosaz J, Fathi MH. Poly (epsilon-caprolactone) incorporated bioactive glass nanoparticles and simvastatin nanocomposite nanofibers: preparation, characterization and in vitro drug release for bone regeneration applications. Chem Eng J. 2013; 228: 1057-65.

[97]

Jo JH, Lee EJ, Shin DS, Kim HE, Kim HW, Koh YH, et al. In vitro/in vivo biocompatibility and mechanical properties of bioactive glass nanofiber and poly(epsilon-caprolactone) composite materials. J Biomed Mater Res B. 2009; 91b1: 213-20.

[98]

Gao CX, Gao Q, Li YD, Rahaman MN, Teramoto A, Abe K. In vitro evaluation of electrospun gelatin-bioactive glass hybrid scaffolds for bone regeneration. J Appl Polym Sci. 2013; 1274: 2588-99.

[99]

Saatchi A, Arani AR, Moghanian A, Mozafari M. Cerium-doped bioactive glass-loaded chitosan/polyethylene oxide nanofiber with elevated antibacterial properties as a potential wound dressing. Ceram Int. 2021; 477: 9447-61.

[100]

Schuhladen K, Raghu SN, Liverani L, Neščáková Z, Boccaccini AR. Production of a novel poly (ε-caprolactone)-methylcellulose electrospun wound dressing by incorporating bioactive glass and Manuka honey. J Biomed Mater Res B Appl Biomater. 2021;1092: 180-92.

[101]

Jana S, Datta P, Das H, Ghosh PR, Kundu B, Nandi SK. Engineering vascularizing electrospun dermal grafts by integrating fish collagen and ion-doped bioactive glass. ACS Biomater Sci Eng. 2022; 82: 734-52.

[102]

Zhou T, Sui BY, Mo XM, Sun J. Multifunctional and biomimetic fish collagen/bioactive glass nanofibers: fabrication, antibacterial activity and inducing skin regeneration in vitro and in vivo. Int J Nanomedicine. 2017; 12: 3495-507.

[103]

Ma WB, Yang XY, Ma L, Wang XG, Zhang L, Yang GJ, et al. Fabrication of bioactive glass-introduced nanofibrous membranes with multifunctions for potential wound dressing. RSC Adv. 2014; 4104: 60114-22.

[104]

Nagrath M, Alhalawani A, Yazdi AR, Towler MR. Bioactive glass fiber fabrication via a combination of sol-gel process with electro-spinning technique. Mater Sci Eng C Mater. 2019; 101: 521-38.

[105]

Lu H, Zhang T, Wang XP, Fang QF. Electrospun submicron bioactive glass fibers for bone tissue scaffold. J Mater Sci Mater Med. 2009; 203: 793-8.

[106]

Hong YL, Chen XS, Jing XB, Fan HS, Gu ZW, Zhang XD. Fabrication and drug delivery of ultrathin mesoporous bioactive glass hollow fibers. Adv Funct Mater. 2010; 209: 1503-10.

[107]

Liverani L, Reiter T, Zheng K, Neščáková Z, Boccaccini AR. Copper-doped cotton-like malleable electrospun bioactive glass fibers for wound healing applications. Mater Lett: X. 2022; 14: 100133.

[108]

Jafari H, Lista A, Siekapen MM, Ghaffari-Bohlouli P, Nie L, Alimoradi H, et al. Fish collagen: extraction, characterization, and applications for biomaterials engineering. Polymers. 2020;1210: 2230.

[109]

Savedboworn W, Kittiphattanabawon P, Benjakul S, Sinthusamran S, Kishimura H. Characteristics of collagen from Rohu (Labeo rohita) skin. J Aquat Food Prod Technol. 2017; 263: 248-57.

[110]

Devi PS, Banerjee S, Chowdhury SR, Kumar GS. Eggshell membrane: a natural biotemplate to synthesize fluorescent gold nanoparticles. RSC Adv. 2012; 230: 11578-85.

[111]

Balaz M.Eggshell membrane biomaterial as a platform for applications in materials science. Acta Biomater. 2014; 109: 3827-43.

[112]

Ahlborn G, Sheldon BW. Identifying the components in eggshell membrane responsible for reducing the heat resistance of bacterial pathogens. J Food Protect. 2006; 694: 729-38.

[113]

Li JY, Zhai D, Lv F, Yu QQ, Ma HS, Yin JB, et al. Preparation of copper-containing bioactive glass/eggshell membrane nanocomposites for improving angiogenesis, antibacterial activity and wound healing. Acta Biomater. 2016; 36: 254-66.

[114]

Frenot A, Henriksson MW, Walkenstrom P. Electrospinning of cellulose-based nanofibers. J Appl Polym Sci. 2007; 1033: 1473-82.

[115]

Portela R, Leal CR, Almeida PL, Sobral RG. Bacterial cellulose: a versatile biopolymer for wound dressing applications. Microb Biotechnol. 2019; 124: 586-610.

[116]

Nasatto PL, Pignon F, Silveira JLM, Duarte MER, Noseda MD, Rinaudo M. Methylcellulose, a cellulose derivative with original physical properties and extended applications. Polymers. 2015; 75: 777-803.

[117]

Vijayakumar V, Samal SK, Mohanty S, Nayak SK. Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management. Int J Biol Macromol. 2019; 122: 137-48.

[118]

Sharaf SS, El-Shafei AM, Refaie R, Gibriel AA, Abdel-Sattar R. Antibacterial and wound healing properties of cellulose acetate electrospun nanofibers loaded with bioactive glass nanoparticles; in-vivo study. Cellulose. 2022; 298: 4565-77.

[119]

Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci. 2006; 317: 603-32.

[120]

Liu HQ, Zhao YC, Cheng S, Huang N, Leng YX. Syntheses of novel chitosan derivative with excellent solubility, anticoagulation, and antibacterial property by chemical modification. J Appl Polym Sci. 2012; 1244: 2641-8.

[121]

Jin J, Song M, Hourston DJ. Novel chitosan-based films cross-linked by genipin with improved physical properties. Biomacromolecules. 2004;51: 162-8.

[122]

Sergi R, Cannillo V, Boccaccini AR, Liverani L. A new generation of electrospun fibers containing bioactive glass particles for wound healing. Materials. 2020;1324: 5651.

[123]

Baino F, Novajra G, Miguez-Pacheco V, Boccaccini AR, Vitale-Brovarone C. Bioactive glasses: special applications outside the skeletal system. J Non-Cryst Solids. 2016; 432: 15-30.

[124]

Kargozar S, Baino F, Hamzehlou S, Hill RG, Mozafari M. Bioactive glasses: sprouting angiogenesis in tissue engineering. Trends Biotechnol. 2018;364: 430-44.

[125]

Brauer DS. Bioactive glasses-structure and properties. Angew Chem Int Ed. 2015;5414: 4160-81.

[126]

Naseri S, Lepry WC, Nazhat SN. Bioactive glasses in wound healing: hope or hype? J Mater Chem B. 2017; 531: 6167-74.

[127]

Goh YF, Alshemary AZ, Akram M, Kadir MRA, Hussain R. In-vitro characterization of antibacterial bioactive glass containing ceria. Ceram Int. 2014; 401: 729-37.

[128]

Pratten J, Nazhat SN, Blaker JJ, Boccaccini AR. In vitro attachment of Staphylococcus epidermidis to surgical sutures with and without Ag-containing bioactive glass coating. J Biomater Appl. 2004; 191: 47-57.

[129]

Luginina M, Schuhladen K, Orru R, Cao G, Boccaccini AR, Liverani L. Electrospun PCL/PGS composite fibers incorporating bioactive glass particles for soft tissue engineering applications. Nanomaterials. 2020; 105: 978.

[130]

Solanki AK, Lali FV, Autefage H, Agarwal S, Nommeots-Nomm A, Metcalfe AD, et al. Bioactive glasses and electrospun composites that release cobalt to stimulate the HIF pathway for wound healing applications. Biomater Res. 2021; 251: 1.

[131]

Sergi R, Cannillo V, Boccaccini AR, Liverani L. Incorporation of bioactive glasses containing Mg, Sr, and Zn in electrospun PCL fibers by using benign solvents. Appl Sci-Basel. 2020; 1016: 5530.

[132]

Kolan KCR, Li J, Roberts S, Semon JA, Park J, Day DE, et al. Near-field electrospinning of a polymer/bioactive glass composite to fabricate 3D biomimetic structures. Int J Bioprinting. 2019; 51: 163.

[133]

Chen S, Galuskova D, Kankova H, Zheng K, Michalek M, Liverani L, et al. Electrospun PCL fiber mats incorporating multi-targeted B and Co co-doped bioactive glass nanoparticles for angiogenesis. Materials. 2020;1318: 4010.

[134]

Lin ZF, Gao WD, Ma LM, Xia H, Xie WH, Zhang Y, et al. Preparation and properties of poly(epsilon-caprolactone)/bioactive glass nanofibre membranes for skin tissue engineering. J Bioact Compat Pol. 2018; 332: 195-209.

[135]

Moura D, Souza MT, Liverani L, Rella G, Luz GM, Mano JF, et al. Development of a bioactive glass-polymer composite for wound healing applications. Mater Sci Eng C. 2017; 76: 224-32.

[136]

Akturk A, Erol-Taygun M, Goller G, Kucubayrak S. Optimization and characterization of poly(epsilon-caprolactone) nanofiber mats doped with bioactive glass and copper metal nanoparticles. Chem Pap. 2021;7511: 5929-43.

[137]

Molavi AM, Sadeghi-Avalshahr A, Nokhasteh S, Naderi-Meshkin H. Enhanced biological properties of collagen/chitosan-coated poly(epsilon-caprolactone) scaffold by surface modification with GHK-Cu peptide and 58S bioglass. Prog Biomater. 2020;9 1-2: 25-34.

[138]

Blaker JJ, Nazhat SN, Boccaccini AR. Development and characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications. Biomaterials. 2004; 257-8: 1319-29.

[139]

Ciraldo FE, Schnepf K, Goldmann WH, Boccaccini AR. Development and characterization of bioactive glass containing composite coatings with ion releasing function for antibiotic-free antibacterial surgical sutures. Materials. 2019; 123: 423.

[140]

Li R, Clark AE, Hench LL. An investigation of bioactive glass powders by sol-gel processing. J Appl Biomater. 1991; 24: 231-9.

[141]

Norris E, Ramos-Rivera C, Poologasundarampillai G, Clark JP, Ju Q, Obata A, et al. Electrospinning 3D bioactive glasses for wound healing. Biomed Mater. 2020;151: 015014.

[142]

Ju Q, Zenji T, Macon ALB, Norris E, Poologasundarampillai G, Obata A, et al. Silver-doped calcium silicate sol-gel glasses with a cotton-wool-like structure for wound healing. Biomater Adv. 2022; 134: 112561.

[143]

Lansdown ABG.Calcium: a potential central regulator in wound healing in the skin. Wound Repair Regen. 2002; 105: 271-85.

[144]

Zhai WY, Lu HX, Chen L, Lin XT, Huang Y, Dai KR, et al. Silicate bioceramics induce angiogenesis during bone regeneration. Acta Biomater. 2012; 81: 341-9.

[145]

Yang QB, Chen SS, Shi HL, Xiao H, Ma YF. In vitro study of improved wound-healing effect of bioactive borate-based glass nano-/micro-fibers. Mater Sci Eng C Mater. 2015; 55: 105-17.

[146]

Dzondo-Gadet M, Mayap-Nzietchueng R, Hess K, Nabet P, Belleville F, Dousset B. Action of boron at the molecular level-effects on transcription and translation in an acellular system. Biol Trace Elem Res. 2002; 851: 23-33.

[147]

Patra CR, Kim JH, Pramanik K, d’Uscio LV, Patra S, Pal K, et al. Reactive oxygen species driven angiogenesis by inorganic nanorods. Nano Lett. 2011; 1111: 4932-8.

[148]

Saha S, Bhattacharjee A, Rahaman SH, Ray S, Marei MK, Jain H, et al. Prospects of antibacterial bioactive glass nanofibers for wound healing: an in vitro study. Int J Appl Glas Sci. 2020; 112: 320-8.

[149]

Huang S, Ingber DE. The structural and mechanical complexity of cell-growth control. Nat Cell Biol. 1999; 15: E131-8.

[150]

Lo CM, Wang HB, Dembo M, Wang YL. Cell movement is guided by the rigidity of the substrate. Biophys J. 2000; 791: 144-52.

[151]

Clark RAF, Ghosh K, Tonnesen MG. Tissue engineering for cutaneous wounds. J Invest Dermatol. 2007; 1275: 1018-29.

[152]

Chiquet M, Reneda AS, Huber F, Fluck M. How do fibroblasts translate mechanical signals into changes in extracellular matrix production? Matrix Biol. 2003; 221: 73-80.

[153]

Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 2003; 1962: 245-50.

[154]

Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006; 1264: 677-89.

[155]

Aboud H, Wagiran H, Hussin R, Ali H, Alajerami Y, Saeed MA. Thermoluminescence properties of the Cu-doped lithium potassium borate glass. Appl Radiat Isotopes. 2014; 90: 35-9.

[156]

Lawrence BJ, Maase EL, Lin HK, Madihally SV. Multilayer composite scaffolds with mechanical properties similar to small intestinal submucosa. J Biomed Mater Res A. 2009; 88a3: 634-43.

[157]

Shailajha S, Geetha K, Vasantharani P, Kadhar SPSA. Effects of copper on the preparation and characterization of Na-Ca-P borate glasses. Spectrochim Acta A. 2015; 138: 846-56.

[158]

Hu HR, Tang Y, Pang LB, Lin CL, Huang WH, Wang DP, et al. Angiogenesis and full-thickness wound healing efficiency of a copper-doped borate bioactive glass/poly(lactic-co-glycolic acid) dressing loaded with vitamin E in vivo and in vitro. ACS Appl Mater Inter. 2018;1027: 22939-50.

[159]

Armstrong DG, Orgill DP, Galiano RD, Glat PM, DiDomenico LA, Carter MJ, et al. A multi-centre, single-blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers. Int Wound J. 2022; 194: 791-801.

[160]

Chouhan D, Chakraborty B, Nandi SK, Mandal BB. Role of non-mulberry silk fibroin in deposition and regulation of extracellular matrix towards accelerated wound healing. Acta Biomater. 2017; 48: 157-74.

[161]

Sun FZ, Nordli HR, Pukstad B, Gamstedt EK, Chinga-Carrasco G. Mechanical characteristics of nanocellulose-PEG bionanocomposite wound dressings in wet conditions. J Mech Behav Biomed. 2017; 69: 377-84.

[162]

Brewer GJ. Avoiding Alzheimer’s disease: the important causative role of divalent copper ingestion. Exp Biol Med. 2019; 2442: 114-9.

[163]

Grada A, Mervis J, Falanga V. Research techniques made simple: animal models of wound healing. J Invest Dermatol. 2018;13810: 2095.

PDF (1179KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉